New Delhi: L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & R&D Consulting Services, has announced the development of a next-generation AI-powered digital twin platform for respiratory diagnostics and lung navigation. The breakthrough solution, created in collaboration with NVIDIA, aims to deliver precision diagnostics, enhance patient care, and improve accessibility for healthcare providers worldwide.
The platform will be unveiled at the Radiological Society of North America (RSNA) 2025. It integrates with CT imaging and leverages deep learning models to create a 3D digital twin of lung anatomy, enabling visualization of airways, blood vessels, lung lobes, and lesions. Powered by NVIDIA MONAI for medical image segmentation and NVIDIA TensorRT for optimized AI inference, the digital twin provides interactive visualization, precise path planning, and navigation support for bronchoscopy—helping clinicians perform complex procedures with greater efficiency.
Key Highlights
- Advanced Visualization: Creates living, evolving 3D models of lung anatomy.
- Clinical Impact: Supports surgical planning for conditions such as lung cancer, COPD, and infectious diseases.
- AI Infrastructure: Combines LTTS’ MedTech expertise with NVIDIA’s accelerated computing and visualization platforms.
- Real-Time Guidance: Enables immersive, interactive simulations for improved diagnostic accuracy and patient outcomes.
LTTS’ proprietary navigation systems and deep domain expertise in medical imaging ensure that static snapshots are transformed into dynamic, clinically meaningful simulations that evolve with the patient. This innovation represents a major leap in surgical planning and personalized healthcare.
Leadership Statements
Alind Saxena, Executive Director and President of Mobility and Tech at LTTS, said: “AI is reshaping what’s possible in diagnostics and medical technology. Our collaboration with NVIDIA combines LTTS’ expertise in AI-driven diagnostics and predictive analytics with NVIDIA’s powerful modeling and visualization platform. This lets us engineer a digital twin platform that not only enhances diagnostic accuracy but also gives clinicians an immersive, real-time planning tool—ultimately helping deliver better outcomes for patients around the world.”
David Niewolny, Director of Business Development for Healthcare/Medical at NVIDIA, added: “Working with LTTS to accelerate the development of AI-enabled medical technology demonstrates how NVIDIA is empowering the healthcare industry with accelerated computing and AI innovation. LTTS is enabling transformative solutions that bring the vision of real-time AI and biological digital twins to clinical practice—delivering interactive visualization and intelligent guidance to help clinicians provide higher-quality care and achieve better outcomes for patients.”
